Related Experiment Video
Updated: Feb 5, 2026

An Improved Method for Rapid Intubation of the Trachea in Mice
Published on: February 22, 2016
An improved LC-MS/MS method for simultaneous evaluation of CYP2C9, CYP2C19, CYP2D6 and CYP3A4 activity
Santosh Kumar Sreevatsav Adiraju1, Kiran Shekar2, John F Fraser2
1Centre for Integrated Preclinical Drug Development, School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
Aim:
To develop an LC-MS/MS assay to quantitate well-tolerated substrates; midazolam (CYP3A), omeprazole (CYP2C19), dextromethorphan (CYP2D6), losartan (CYP2C9) and their respective metabolites' concentrations in plasma samples.
Patients & Methods:
A solid-phase extraction method was optimized to extract analytes of interest simultaneously from human plasma samples. The assay analyzed plasma samples collected from patients who received equal or lower than therapeutic doses of CYP substrates.
Results:
This assay was validated based on the European Medicines Agency guideline for bioanalytical method validation and was sensitive, linear, accurate and precise with acceptable recovery and matrix effects.
Conclusion:
Small sample volume and dose of cytochrome P450 substrates, short-run time, using stable isotope internal standards and being cost effective are the major advantages of the assay.
Related Concept Videos
Improving Translational Accuracy
Improving Translational Accuracy
Secondary Active Transport
Self-Evaluation: Self-Enhancement and Self-Verification
Co-activators and Co-repressors
tRNA Activation

